Antibiotic and immuno-oncology drug discovery startup
| Date | Round | Amount |
|---|---|---|
| Feb 2022 | Series B Biotech startup Bugworks Research raised an $18M Series B1 led by Lightrock India to advance its broad-spectrum antibacterial and immuno-oncology programs. | $18M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.